Text Version
Entrez PubMed Overview Help | FAQ Tutorial New/Noteworthy E-Utilities
PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher Clinical Queries LinkOut Cubby
Related Resources Order Documents NLM
Gateway TOXNET Consumer
Health Clinical Alerts ClinicalTrials.gov PubMed
Central
Privacy Policy
|
|
-
-
[Worsening of autosomal
dominant restless legs syndrome after use of mirtazapine: case
report]
[Article in Portuguese]
Teive HA, de
Quadros A, Barros FC, Werneck LC.
Servico de Neurologia,
Departamento de Clinica Medica, Hospital de Clinicas, Universidade
Federal de Parana, Curitiba, PR, Brasil. hagtevive@mps.com.br
We
report the case of a 78 years old female patient with primary restless
legs syndrome (RLS) with an autosomal dominant pattern of inheritance.
In addition, the patient also had depression. We emphasize the worsening
of symptoms of RLS after the use of a selective serotonin uptake
inhibitor (mirtazapine), with improvement after the drug was
discontinued, and an excellent recovery with the use of low dose
dopaminergic agonist (pramipexol).
Publication Types:
PMID: 12563401 [PubMed - indexed for
MEDLINE]
|